Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 33

1.

Improved cellular uptake of perfluorocarbon nanoparticles for in vivo murine cardiac 19F MRS/MRI and temporal tracking of progenitor cells.

Constantinides C, McNeill E, Carnicer R, Al Haj Zen A, Sainz-Urruela R, Shaw A, Patel J, Swider E, Alonaizan R, Potamiti L, Hadjisavvas A, Padilla-Parra S, Kyriacou K, Srinivas M, Carr CA.

Nanomedicine. 2019 Jun;18:391-401. doi: 10.1016/j.nano.2018.10.014. Epub 2018 Nov 16.

PMID:
30448526
2.

In Vivo Tracking and 1H/19F Magnetic Resonance Imaging of Biodegradable Polyhydroxyalkanoate/Polycaprolactone Blend Scaffolds Seeded with Labeled Cardiac Stem Cells.

Constantinides C, Basnett P, Lukasiewicz B, Carnicer R, Swider E, Majid QA, Srinivas M, Carr CA, Roy I.

ACS Appl Mater Interfaces. 2018 Aug 1;10(30):25056-25068. doi: 10.1021/acsami.8b06096. Epub 2018 Jul 18.

3.

Fast, quantitative, murine cardiac 19F MRI/MRS of PFCE-labeled progenitor stem cells and macrophages at 9.4T.

Constantinides C, Maguire M, McNeill E, Carnicer R, Swider E, Srinivas M, Carr CA, Schneider JE.

PLoS One. 2018 Jan 11;13(1):e0190558. doi: 10.1371/journal.pone.0190558. eCollection 2018.

4.

The Subcellular Localisation of Neuronal Nitric Oxide Synthase Determines the Downstream Effects of NO on Myocardial Function.

Carnicer R, Suffredini S, Liu X, Reilly S, Simon JN, Surdo NC, Zhang YH, Lygate CA, Channon KM, Casadei B.

Cardiovasc Res. 2017 Feb 1. doi: 10.1093/cvr/cvx002. [Epub ahead of print] No abstract available.

5.

Protein Inhibitor of NOS1 Plays a Central Role in the Regulation of NOS1 Activity in Human Dilated Hearts.

Roselló-Lletí E, Tarazón E, Ortega A, Gil-Cayuela C, Carnicer R, Lago F, González-Juanatey JR, Portolés M, Rivera M.

Sci Rep. 2016 Aug 2;6:30902. doi: 10.1038/srep30902.

6.

Up-regulation of miR-31 in human atrial fibrillation begets the arrhythmia by depleting dystrophin and neuronal nitric oxide synthase.

Reilly SN, Liu X, Carnicer R, Recalde A, Muszkiewicz A, Jayaram R, Carena MC, Wijesurendra R, Stefanini M, Surdo NC, Lomas O, Ratnatunga C, Sayeed R, Krasopoulos G, Rajakumar T, Bueno-Orovio A, Verheule S, Fulga TA, Rodriguez B, Schotten U, Casadei B.

Sci Transl Med. 2016 May 25;8(340):340ra74. doi: 10.1126/scitranslmed.aac4296.

7.

Human Ischemic Cardiomyopathy Shows Cardiac Nos1 Translocation and its Increased Levels are Related to Left Ventricular Performance.

Roselló-Lletí E, Carnicer R, Tarazón E, Ortega A, Gil-Cayuela C, Lago F, González-Juanatey JR, Portolés M, Rivera M.

Sci Rep. 2016 Apr 4;6:24060. doi: 10.1038/srep24060.

8.

Tetrahydrobiopterin Protects Against Hypertrophic Heart Disease Independent of Myocardial Nitric Oxide Synthase Coupling.

Hashimoto T, Sivakumaran V, Carnicer R, Zhu G, Hahn VS, Bedja D, Recalde A, Duglan D, Channon KM, Casadei B, Kass DA.

J Am Heart Assoc. 2016 Mar 21;5(3):e003208. doi: 10.1161/JAHA.116.003208.

9.

Evaluation of the role of miR-31-dependent reduction in dystrophin and nNOS on atrial-fibrillation-induced electrical remodelling in man.

Reilly S, Liu X, Carnicer R, Rajakumar T, Sayeed R, Krasopoulos G, Verheule S, Fulga T, Schotten U, Casadei B.

Lancet. 2015 Feb 26;385 Suppl 1:S82. doi: 10.1016/S0140-6736(15)60397-X.

PMID:
26312904
10.

Adenoviral transduction of FRET-based biosensors for cAMP in primary adult mouse cardiomyocytes.

Lomas O, Brescia M, Carnicer R, Monterisi S, Surdo NC, Zaccolo M.

Methods Mol Biol. 2015;1294:103-15. doi: 10.1007/978-1-4939-2537-7_8.

PMID:
25783880
11.

Nitric oxide synthase regulation of cardiac excitation-contraction coupling in health and disease.

Simon JN, Duglan D, Casadei B, Carnicer R.

J Mol Cell Cardiol. 2014 Aug;73:80-91. doi: 10.1016/j.yjmcc.2014.03.004. Epub 2014 Mar 13. Review.

PMID:
24631761
12.

Regulation of endothelial nitric-oxide synthase (NOS) S-glutathionylation by neuronal NOS: evidence of a functional interaction between myocardial constitutive NOS isoforms.

Idigo WO, Reilly S, Zhang MH, Zhang YH, Jayaram R, Carnicer R, Crabtree MJ, Balligand JL, Casadei B.

J Biol Chem. 2012 Dec 21;287(52):43665-73. doi: 10.1074/jbc.M112.412031. Epub 2012 Oct 22.

13.

Nitric oxide synthases in heart failure.

Carnicer R, Crabtree MJ, Sivakumaran V, Casadei B, Kass DA.

Antioxid Redox Signal. 2013 Mar 20;18(9):1078-99. doi: 10.1089/ars.2012.4824. Epub 2012 Sep 20. Review.

14.

Cardiomyocyte GTP cyclohydrolase 1 and tetrahydrobiopterin increase NOS1 activity and accelerate myocardial relaxation.

Carnicer R, Hale AB, Suffredini S, Liu X, Reilly S, Zhang MH, Surdo NC, Bendall JK, Crabtree MJ, Lim GB, Alp NJ, Channon KM, Casadei B.

Circ Res. 2012 Aug 31;111(6):718-27. doi: 10.1161/CIRCRESAHA.112.274464. Epub 2012 Jul 12.

PMID:
22798524
15.

Nitric oxide-releasing agent, LA419, reduces atherogenesis in apolipoprotein E-deficient mice.

Carnicer R, Guillén N, Arbonés-Mainar JM, Navarro MA, Guzmán MA, Barranquero C, Arnal C, Gascón S, Acín S, Mourelle M, Osada J.

Naunyn Schmiedebergs Arch Pharmacol. 2009 May;379(5):489-500. doi: 10.1007/s00210-008-0377-5. Epub 2008 Dec 3.

PMID:
19050853
16.

Genetic background in apolipoprotein A-I and cystathionine beta-synthase deficiency.

Carnicer R, Guzman MA, Acin S, Surra JC, Navarro MA, Arbones-Mainar JM, Arnal C, Morales R, Osada J.

Front Biosci. 2008 May 1;13:5155-62.

PMID:
18508577
17.

Simvastatin reverses the hypertension of heterozygous mice lacking cystathionine beta-synthase and apolipoprotein A-I.

Carnicer R, Navarro MA, Guillén N, Arbonés-Mainar JM, Surra JC, Acín S, Osada J.

Naunyn Schmiedebergs Arch Pharmacol. 2008 Mar;377(1):35-43. doi: 10.1007/s00210-007-0247-6. Epub 2008 Jan 26.

PMID:
18224302
18.

Squalene in a sex-dependent manner modulates atherosclerotic lesion which correlates with hepatic fat content in apoE-knockout male mice.

Guillén N, Acín S, Navarro MA, Perona JS, Arbonés-Mainar JM, Arnal C, Sarría AJ, Surra JC, Carnicer R, Orman I, Segovia JC, Ruiz-Gutiérrez V, Osada J.

Atherosclerosis. 2008 Mar;197(1):72-83. Epub 2007 Sep 12.

PMID:
17854812
19.

Extra virgin olive oils increase hepatic fat accumulation and hepatic antioxidant protein levels in APOE-/- mice.

Arbones-Mainar JM, Ross K, Rucklidge GJ, Reid M, Duncan G, Arthur JR, Horgan GW, Navarro MA, Carnicer R, Arnal C, Osada J, de Roos B.

J Proteome Res. 2007 Oct;6(10):4041-54. Epub 2007 Sep 11.

PMID:
17845022
20.

Genetically based hypertension generated through interaction of mild hypoalphalipoproteinemia and mild hyperhomocysteinemia.

Carnicer R, Navarro MA, Arbonés-Mainar JM, Arnal C, Surra JC, Acín S, Sarría A, Blanco-Vaca F, Maeda N, Osada J.

J Hypertens. 2007 Aug;25(8):1597-607.

PMID:
17620955
21.

Microarray analysis of hepatic genes differentially expressed in the presence of the unsaponifiable fraction of olive oil in apolipoprotein E-deficient mice.

Acín S, Navarro MA, Perona JS, Surra JC, Guillen N, Arnal C, Sarría AJ, Arbonés-Mainar JM, Carnicer R, Ruiz-Gutiérrez V, Osada J.

Br J Nutr. 2007 Apr;97(4):628-38.

PMID:
17349074
22.

Accelerated atherosclerosis in apolipoprotein E-deficient mice fed Western diets containing palm oil compared with extra virgin olive oils: a role for small, dense high-density lipoproteins.

Arbonés-Mainar JM, Navarro MA, Carnicer R, Guillén N, Surra JC, Acín S, Guzmán MA, Sarría AJ, Arnal C, Aguilera MP, Jiménez A, Beltrán G, Uceda M, Osada J.

Atherosclerosis. 2007 Oct;194(2):372-82. Epub 2006 Dec 4.

PMID:
17141784
23.

Folic acid supplementation delays atherosclerotic lesion development in apoE-deficient mice.

Carnicer R, Navarro MA, Arbonés-Mainar JM, Acín S, Guzmán MA, Surra JC, Arnal C, de Las Heras M, Blanco-Vaca F, Osada J.

Life Sci. 2007 Jan 23;80(7):638-43. Epub 2006 Nov 10.

PMID:
17118406
24.

Olive oil preparation determines the atherosclerotic protection in apolipoprotein E knockout mice.

Acín S, Navarro MA, Perona JS, Arbonés-Mainar JM, Surra JC, Guzmán MA, Carnicer R, Arnal C, Orman I, Segovia JC, Osada J, Ruiz-Gutiérrez V.

J Nutr Biochem. 2007 Jun;18(6):418-24. Epub 2006 Oct 17.

PMID:
17049830
25.

Cystathionine beta-synthase is essential for female reproductive function.

Guzmán MA, Navarro MA, Carnicer R, Sarría AJ, Acín S, Arnal C, Muniesa P, Surra JC, Arbonés-Mainar JM, Maeda N, Osada J.

Hum Mol Genet. 2006 Nov 1;15(21):3168-76. Epub 2006 Sep 19.

PMID:
16984962
26.

Hydroxytyrosol administration enhances atherosclerotic lesion development in apo E deficient mice.

Acín S, Navarro MA, Arbonés-Mainar JM, Guillén N, Sarría AJ, Carnicer R, Surra JC, Orman I, Segovia JC, Torre Rde L, Covas MI, Fernández-Bolaños J, Ruiz-Gutiérrez V, Osada J.

J Biochem. 2006 Sep;140(3):383-91. Epub 2006 Jul 27.

PMID:
16873395
27.

Selective effect of conjugated linoleic acid isomers on atherosclerotic lesion development in apolipoprotein E knockout mice.

Arbonés-Mainar JM, Navarro MA, Guzmán MA, Arnal C, Surra JC, Acín S, Carnicer R, Osada J, Roche HM.

Atherosclerosis. 2006 Dec;189(2):318-27. Epub 2006 Mar 13.

PMID:
16530768
28.

Trans-10, cis-12- and cis-9, trans-11-conjugated linoleic acid isomers selectively modify HDL-apolipoprotein composition in apolipoprotein E knockout mice.

Arbonés-Mainar JM, Navarro MA, Acín S, Guzmán MA, Arnal C, Surra JC, Carnicer R, Roche HM, Osada J.

J Nutr. 2006 Feb;136(2):353-9.

PMID:
16424111
29.

Understanding the role of dietary components on atherosclerosis using genetic engineered mouse models.

Sarria AJ, Surra JC, Acin S, Carnicer R, Navarro MA, Arbones-Mainar JM, Guillen N, Martinez-Gracia MV, Arnal C, Osada J.

Front Biosci. 2006 Jan 1;11:955-67. Review.

PMID:
16146786
30.

Dietary cholesterol suppresses the ability of olive oil to delay the development of atherosclerotic lesions in apolipoprotein E knockout mice.

Acín S, Navarro MA, Carnicer R, Arbonés-Mainar JM, Guzmán MA, Arnal C, Beltrán G, Uceda M, Maeda N, Osada J.

Atherosclerosis. 2005 Sep;182(1):17-28. Epub 2005 Apr 7.

PMID:
16115471
31.

Immune-regulation of the apolipoprotein A-I/C-III/A-IV gene cluster in experimental inflammation.

Navarro MA, Carpintero R, Acín S, Arbonés-Mainar JM, Calleja L, Carnicer R, Surra JC, Guzmán-García MA, González-Ramón N, Iturralde M, Lampreave F, Piñeiro A, Osada J.

Cytokine. 2005 Jul 7;31(1):52-63.

PMID:
15878672
32.

Response of ApoA-IV in pigs to long-term increased dietary oil intake and to the degree of unsaturation of the fatty acids.

Navarro MA, Acín S, Carnicer R, Guzmán-García MA, Arbonés-Mainar JM, Surra JC, Cebrián JA, Arnal C, Isabel B, López-Bote CJ, Osada J.

Br J Nutr. 2004 Nov;92(5):763-9.

PMID:
15533264
33.

Cloning, characterization and comparative analysis of pig plasma apolipoprotein A-IV.

Navarro MA, Acín S, Iturralde M, Calleja L, Carnicer R, Guzmán-García MA, González-Ramón N, Mata P, Isabel B, López-Bote CJ, Lampreave F, Piñeiro A, Osada J.

Gene. 2004 Jan 21;325:157-64.

PMID:
14697520

Supplemental Content

Loading ...
Support Center